Access Bio (Korea) Buy Hold or Sell Recommendation

950130 Stock  KRW 7,400  20.00  0.27%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Access Bio is 'Not Rated'. Macroaxis provides Access Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 950130 positions. The advice algorithm takes into account all of Access Bio's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Access Bio's buy or sell advice are summarized below:
Real Value
0.0
Hype Value
0.0
Market Value
7.4 K
Naive Value
8.2 K
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Access Bio given historical horizon and risk tolerance towards Access Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for Access Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Access Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Access and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Access Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

Execute Access Bio Buy or Sell Advice

The Access recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Access Bio. Macroaxis does not own or have any residual interests in Access Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Access Bio's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Access BioBuy Access Bio
Strong Sell

Market Performance

Very WeakDetails

Volatility

Out of controlDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Access Bio has a Mean Deviation of 1.74, Standard Deviation of 2.92 and Variance of 8.52
Macroaxis provides advice on Access Bio to complement and cross-verify current analyst consensus on Access Bio. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Access Bio is not overpriced, please confirm all Access Bio fundamentals, including its return on asset, operating margin, shares outstanding, as well as the relationship between the profit margin and current valuation .

Access Bio Trading Alerts and Improvement Suggestions

Access Bio generated a negative expected return over the last 90 days
About 25.0% of the company shares are owned by insiders or employees

Access Bio Returns Distribution Density

The distribution of Access Bio's historical returns is an attempt to chart the uncertainty of Access Bio's future price movements. The chart of the probability distribution of Access Bio daily returns describes the distribution of returns around its average expected value. We use Access Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Access Bio returns is essential to provide solid investment advice for Access Bio.
Mean Return
-0.26
Value At Risk
-3.27
Potential Upside
3.33
Standard Deviation
2.92
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Access Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Access Bio Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Access Bio or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Access Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Access stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.28
β
Beta against NYSE Composite0.12
σ
Overall volatility
2.23
Ir
Information ratio -0.13

Access Bio Volatility Alert

Access Bio exhibits very low volatility with skewness of -0.02 and kurtosis of 9.21. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Access Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Access Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Access Bio Fundamentals Vs Peers

Comparing Access Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Access Bio's direct or indirect competition across all of the common fundamentals between Access Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Access Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Access Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Access Bio by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Access Bio to competition
FundamentalsAccess BioPeer Average
Return On Equity108.02-0.31
Return On Asset0.35-0.14
Profit Margin0.40 %(1.27) %
Operating Margin0.55 %(5.51) %
Current Valuation1.03 T16.62 B
Shares Outstanding26.79 M571.82 M
Shares Owned By Insiders25.25 %10.09 %
Shares Owned By Institutions0.08 %39.21 %
Price To Earning149.71 X28.72 X
Price To Sales1.44 X11.42 X
Revenue441.37 M9.43 B
Gross Profit90.63 B27.38 B
EBITDA69.95 B3.9 B
Net Income166.09 M570.98 M
Cash And Equivalents167.93 M2.7 B
Cash Per Share828.78 X5.01 X
Total Debt10.13 M5.32 B
Debt To Equity0.13 %48.70 %
Current Ratio16.48 X2.16 X
Book Value Per Share2,289 X1.93 K
Cash Flow From Operations137.9 M971.22 M
Number Of Employees6918.84 K
Beta0.28-0.15
Market Capitalization292.03 B19.03 B
Total Asset372.85 M29.47 B
Retained Earnings18.8 B9.33 B
Working Capital43.68 B1.48 B
Current Asset45.78 B9.34 B
Current Liabilities2.1 B7.9 B
Net Asset372.85 M

Access Bio Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Access . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Access Bio Buy or Sell Advice

When is the right time to buy or sell Access Bio? Buying financial instruments such as Access Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Access Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sport Products Thematic Idea Now

Sport Products
Sport Products Theme
Companies manufacturing sporting goods and accessories. The Sport Products theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
View All  Next Launch
Check out Access Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note that the Access Bio information on this page should be used as a complementary analysis to other Access Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Access Stock analysis

When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Please note, there is a significant difference between Access Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Access Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Access Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.